Abstract. Calcineurin is a calcium-dependent protein phosphatase that functions in T cell activation. We present evidence that calcineurin functions more generally in calcium-triggered apoptosis in mammalian cells deprived of growth factors. Specifically, expression of epitope-tagged calcineurin A induces rapid cell death upon calcium signaling in the absence of growth factors. We show that this apoptosis does not require new protein synthesis and therefore calcineurin must operate through existing substrates. Co-expression of the Bcl-2 protooncogene efficiently blocks calcineurin-induced cell death. Significantly, we demonstrate that a calciumindependent calcineurin mutant induces apoptosis in the absence of calcium, and that this apoptotic response is a direct consequence of calcineurin's phosphatase activity. These data suggest that calcineurin plays an important role in mediating the upstream events in calcium-activated cell death.
to T cell receptor (TCR) 1 activation underscore the complex interactions between apoptotic and growth pathways. Stimulation of the TCR on immature T cells drives them into apoptosis rather than the proliferative state assumed by mature T cells (Smith et al., 1989; Ucker et al., 1989) . Moreover, even mature T ceils undergo apoptosis when confronted with continuous TCR stimulation, suggesting a wide use of cell death at many stages of the immune response (Singer and Abbas, 1994) .
Calcium signaling is upstream of certain pathways that lead to apoptosis, including neuronal cell death via glutamate-induced excitotoxicity and cell death in T cells (Choi, 1992; Reed, 1994) . Additionally, calcium ionophores cause apoptosis in a number of experimental systems, implying that elevated intracellular calcium influences the decision to enter apoptosis. The ability of Bcl-2 to block most cases of calcium-induced apoptosis suggests that calcium stimulates a common pathway affecting the commitment to cell death (Barr and Tomei, 1994; Reed, 1994) . While the mechanism of Bcl-2 action is uncertain, it has been implicated in antioxidant pathways to prevent the generation of reactive oxygen species associated with cell death (Hockenbery et al., 1993) . More recently, Bcl-2 has been implicated in regulation of calcium efflux from the endoplasmic reticulum, and may thereby influence calcium-dependent apoptotic pathways (Lam et al., 1994) .
Despite extensive studies linking calcium to cell death, the immediate targets of this calcium flux remain largely unknown. One potential mediator of calcium signaling during apoptosis is the family of calcium-activated phosphatases known as calcineurin (protein phosphatase 2B; Klee et al., 1988; . We show here that expression of this calcium-activated phosphatase in mammalian cells greatly potentiates the cell death due to calcium signaling. Moreover, a constitutively active, calcium-independent calcineurin mutant completely bypasses the requirement for calcium signaling in this cell death.
Materials and Methods

Cell Culture
BHK-21 cells were obtained from the American Type Culture Collection (Rockville, MD) and maintained in a 5% CO2 atmosphere at 37°C in DME (GIBCO BRL, Gaithersburg, MD) supplemented with 10% fetal bovine serum (Hyclone Labs., Logan, UT), 2 mM glutamine (GIBCO BRL), and 100 i~g/ml of penicillin-streptomycin (GIBCO BRL).
Construction of Calcineurin A and B Expression Vectors
The eDNA encoding human calcineurin A (CnA [3-isotype; , and human calcineurin B were obtained from a T cell hgtl0 library using oligonucleotides as a hybridization probes (Maniatis et aL, 1982) . CnA was cloned into the mammalian expression vector pCMV1 (Pharmacia, Piscataway, NJ) 200-bp '5-untranslated sequence from human lamin A and an NH2-terminal influenza hemagglutinin (HA)-tag using oligonucleotides and PCR techniques (Heald et al., 1993) . CnA lacking the autoinhibitory domain and the CaM binding domain (ACnA) was constructed using PCR to introduce a stop codon after N4o7. CnB was cloned into pCMV1 after the lamin untranslated region but without an epitope tag. The Bcl-2 expression vector, pCMV-bcl.2, was a generous gift of Stanley Korsmeyer (Washington University School of Medicine, St. Louis, MO).
DNA Transfections
DNA transfections were performed as described previously (Heald et al., 1993) . 16,000 cells were plated onto each coverslip in 400 ~l of medium. On day 1, a total of 2 pLg of cesium chloride-purified plasmid DNA was added to 30 ~l of 0.2 M CaC12 and precipitated by adding 30 izL of 2× Hepes-buffered saline over 15 s with stirring. After 20 min, 350 p.1 of complete medium was added to the DNA precipitate, and the mixture applied to the cells. Each coverslip was allowed to incubate in the tissue culture incubator for 4 h. The coverslips were then washed twice with complete medium and returned to the incubator for an additional 12 h.
Immunofluorescence
Cells on coverslips were fixed in 3 % formaldehyde (Baker Co., Inc., Sanford, ME) in PBS for 10 min and then washed three times with 0.1% NP-40 (Sigma Chem. Co., St. Louis, MO) in PBS (PBS-NP-40). Primary antibodies were incubated on the coverslips for 30 min, followed by four rapid rinses with PBS-NP-40. The 9E10 anti-c-myc epitope monoclonal antibody was obtained from the American Type Culture Collection, and the anti-HA epitope monoclonal antibody (12CA5) purchased from BAbCO (Berkeley, CA). The polyclonal antibody against the HA epitope was purchased from MBL International Corporation (MCI, Watertown, MA). CyLconjugated secondary antibodies (Jackson ImmunoResearch Labs., Inc., West Grove, PA) were incubated on the coverslips for an additional 30 rain. DNA was labeled using Hoechst dye 33258 (Sigma Chem. Co.) at 10 p~g/ml PBS-NP40 for 1 min. Coverslips were mounted on glass slides in 90% glycerol, 20 mM Tris-HCl (pH 9.35).
Western Blotting
Coverslips were washed twice with ice-cold PBS, and the cells were extracted with 200 pA of pre-heated (70°C) 2× SDS sample buffer containing 10% 2-mercaptoethanol. The extract was transferred to a microcentrifuge tube, boiled for 5 rain, and centrifuged at 10,000 g for 10 min. 25 ~l of each sample was analyzed by 8% SDS gel electrophoresis and electrophoretically transferred to Immobilon membranes (Millipore Corp., Bedford, MA). The membranes were blocked overnight in 0.1% Tween-20 PBS (0.1% Tween-PBS) containing 5% nonfat dry milk and incubated in primary antibody for 1 h at room temperature. After four 5-min washes with blocking solution, membranes were incubated with goat anti-rabbit antibody conjugated to horseradish peroxidase (Jackson ImmunoResearch Labs., Inc.) for 1 h. Membranes were then washed and developed using chemiluminescence reagents (ECL; Amersham Corp., Arlington Heights, IL) and exposed to XAR-5 film (Kodak).
DNA Nick End Labeling (TUNEL Method)
To detect DNA fragmentation in situ, we modified the previously described TUNEL method (Tilly and Hsueh, 1993; Surh and Sprent, 1994) as follows. Cells were fixed and washed with PBS-NP-40 and TdT buffer (0.5 M cacodylate, 25 mM Tris, pH 6.8, 150 mM NaC1, 5 mM CoC12, 0.5 mM DTT, and 0.05% BSA), and then incubated for 1 h at 37°C with 2-5 p.M digoxigenin-conjugated dUTP (Boehringer Mannheim Biochemicals, Indianapolis, IN) and 5-10 U TdT (terminal transferase; Promega Biotec, Madison,WI) in 50 p.l TdT buffer per coverslip. After washing and blocking, cells were incubated with 0.5 ~,g/ml anti-digoxigenin mouse monoclonal antibody (Boehringer Mannheim Biochemicals), washed, and then incubated with an FITC-labeled anti-mouse antibody (Jackson ImmunoResearch Labs., Inc.).
Immunoprecipitations and Calcineurin
Phosphatase Assays
Transfected cells on coverslips were lysed in 200 i~l of buffer A (50 mM Tris-HC1, pH 7.5, i mM EDTA, 0.5% Tween-20, 0.5 mg/ml BSA, 1 mM DTT, I mM PMSF, 1 p~g/ml leupeptin and 1 I~g/ml pepstatin), transferred to a microfuge tube, and centrifuged at 10,000 g for 5 min at 4°C. The supernatant was transferred to a new tube and 5 ~1 of the anti-HA epitope (12CA5) monoclonal antibody (BAbCO) and 30 p.1 of protein G-Sepharose (1:1 slurry; Sigma Chem. Co.) were added. Tubes were rotated at 4°C for I h. The Sepharose beads were pelleted by centrifugation and washed three times in buffer A. Phosphatase activity associated with the immunoprecipitates was determined by following [32p]phosphate released from the RII peptide essentially as described (Milan et al., 1994) .
Calcineurin activity from whole cell lysates of transfected and mocktransfected cells was determined by a modification of the assay developed by Fruman and colleagues . Cells were scraped from coverslips in 200 ~l of PBS, pelleted at 10,000 g for 15 s, resuspended in 50 I~l hypotonic lysis buffer (50 mM Tris-HC1, pH 7.4, 1 mM EDTA, 1 mM CaCl2, 1 mM PMSF, 1 p~g/ml pepstatin, 1 p.g/ml leupeptin, 1 mM DTr), and subjected to three rounds of freeze-thaw. After removing cell debris by centrifugation, 50 ixl of phosphatase buffer (100 mM Tris-HCl, pH 7.4, 1 mM MnC12, 0.1 mM CaC12, 0.5 mg/ml BSA, 100 nM calmodulin, and 0.5 mM DTT) was added to the supernatant. 500 nM okadaic acid was added to the reactions to suppress endogenous protein phosphatases PP1 and PP2A . The SEp-labeled Rll peptide was incubated in the extracts for 30 min at 30°C. To determine the specific contribution of ACnA to the phosphatase activity of the lysates, 1 mM EGTA was added prior to the start of the reaction to suppress endogenous calcineurin activity. The effects of immunophilin--drug complexes on calcineurin activity of these lysates was determined using 0.5 ~M cyclosporin A (CsA) and 1 p.M human cyclophilin B (Price et al., 1991) . Reactions were stopped by adding 500 p,l of stop buffer (10% TCA, 0.1 M sodium phosphate) and 10 p.l of 10 mg/ml BSA to each tube. These tubes were incubated on ice for 10 min, centrifuged at 10,000 g for 10 min, and the released [sZP]phosphate was determined as described (Milan et al., 1994) .
Results
Calcineurin Induces Calcium-dependent Cell Death in the Absence of Growth Factors
To assess the effect of exogenous calcineurin expression on mammalian cells, we transfected BHK cells with vectors expressing an HA-epitope-tagged catalytic subunit of calcineurin (~-isotype of CnA) and its regulatory subunit, CnB Milan et al., 1994 ; Fig. 1 A) . Co-transfection of the two calcineurin subunits appears to be essential for efficient calcineurin expression in mammalian cellsl as immunoblot- ting with anti-HA antibodies revealed considerably higher levels of CnA in cells co-expressing CnA and CnB, compared to those expressing CnA alone (Fig. 1 B) . It is likely that the assembly of CnB onto its binding site on CnA acts to protect CnA from proteolytic degradation in the cell (Milan et al., 1994) . Indirect immunofluorescence using the anti-HA monoclonal antibody detected HA-tagged CnA in the cytoplasm of transfected cells, and showed that co-expressing CnB along with CnA yields more cells with detectable levels of CnA (Fig. 1 C) . The indirect immunofluorescence also revealed that the vast majority of BHK cells grown in normal media appears to tolerate the coexpression of HA-CnA and -CnB. However, approximately 3% of transfected cells displayed hypercondensed nuclei and cytoskeletal changes reminiscent of cells undergoing apoptosis (Kerr et al., 1994) . Since calcineurin activity is highly dependent on a transient rise in intracellular calcium (Klee et al., 1988) , we asked whether stimulating calcineurin activity by exposing cells to calcium ionophores would provoke increased rates of apoptosis in calcineurin-transfected cells. Cells co-expressing HA-CnA and -CnB for 16 h were treated with the calcium ionophore ionomycin, and scored for the apoptotic phenotype. Despite a 4-h incubation with ionomycin (0.25 }xM), calcineurin-transfected cells showed only a modest increase in the rate of apoptosis (Fig. 2 A) . We then considered the possibility that, as with c-myc over-expression (Evan et al., 1992) , growth factor pathways inhibit apoptosis in calcineurin-transfected cells. We therefore stimulated calcineurin-transfected cells with calcium ionophores after 4 h of serum deprivation. Significantly, more than 60% of the transfected cells entered apoptosis within 4 h (Fig. 2  A) . The process of apoptosis in these cells was very rapid: cytoplasmic retraction was apparent within 15 min of calcium ionophore treatment, and nuclear condensation was obvious at 30 min (Fig. 2 B) . By 4 h, cells were rounded and had nuclei with multiple bodies of hypercondensed chromatin.
To further characterize the apparent apoptotic events, calcineurin-transfected cells were treated with calcium ionophores with and without serum deprivation, and genomic D N A subsequently probed for the presence of strand breaks using the terminal deoxynucleotidyl transferase (TdT)-mediated UTP nick end-labeling (TUNEL) method (Fig. 3; Tilly and Hsueh, 1993) . Calcium-activated cells grown in high serum showed no incorporation of labeled nucleotides (Fig. 3) . In contrast, apoptotic nuclei of calcium activated, serum-deprived cells showed strong incorporation of labeled nucleotides indicative of multiple nicks in nuclear D N A (Fig. 3 ). These results demonstrate that transfected calcineurin induces apoptosis in a calcium-dependent manner and that this process of cell death is blocked by growth factors.
We also note that non-transfected BHK cells, or those transfected with the regulatory subunit CnB alone, undergo apoptosis when serum deprived for 4 h and subsequently treated with ionomycin. However, the percentage of apoptotic cells is only 7.5% compared to 65% in CnA/ CnB-transfected cells (not shown).
Calcineurin Acts on Existing Substrates to Promote Apoptosis
To determine whether calcineurin-induced apoptosis in BHK cells requires new protein synthesis, we treated cells co-expressing CnA and CnB with the protein synthesis inhibitor cycloheximide (36 }xM) immediately prior to serum deprivation. 1 h after calcium ionophore treatment in the presence or absence of cycloheximide, cells were scored for changes in cytoplasmic and nuclear structure characteristic of apoptosis. Cycloheximide showed no effect on the progression of serum-deprived, calcineurin-transfected cells toward apoptosis upon calcium ionophore treatment, an indication that calcineurin stimulates cell death by acting on existing substrates in the cell (Fig. 4 A, lane 3) . Direct measurement of the inhibition of protein synthesis by 36 ixM cycloheximide revealed an 83% decrease in the incorporation of [35S]methionine into polypeptides (not shown). Significantly, cycloheximide treatment in the absence of ionomycin did not promote cell death in either the serum deprived cells or those grown in 10% FCS (Fig.   4 A, lanes 1 and 4) . In contrast, cycloheximide appears to neutralize the ability of high serum to block calcineurininduced cell death (Fig. 4 A, lane 6 ). In this case it is likely that cycloheximide is preventing the synthesis of factors required by the cell for survival.
Calcineurin-induced Apoptosis Is Suppressed by Bcl-2 Expression
The oncoprotein Bcl-2, and its homolog in C. elegans encoded by ced9, appear to play a major role in suppressing cell death provoked by a wide variety of stimuli (Sentman et al., 1991; Barr and Tomei, 1994; Reed, 1994) . To deter- Figure 3 . mine whether Bcl-2 can regulate calcineurin-induced apoptosis, we assayed the interaction of Bcl-2 and calcineurin in B H K fibroblasts. Cells expressing CnA, CnB, and Bcl-2 were found to be markedly resistant to apoptosis induced by growth factor withdrawal and ionomycin treatment in comparison to cells not transfected with the Bcl-2 expression vector (Fig. 4 B) . These data suggest that the actions of Bcl-2 are dominant over those of calcineurin in cell death, although they fail to address whether Bcl-2 is acting upstream or downstream of calcineurin. Regardless, calcineurin appears to function in a pathway of cell death regulated by Bcl-2.
Calcium-independent Calcineurin Mutant Promotes Apoptosis in the Absence of Calcium Signaling
Although calcineurin-transfected cells undergo rapid and efficient apoptosis upon exposure to calcium ionophores, it was formally possible that the calcium influx was activating endogenous enzymes which in turn trigger cell death. To circumvent the requirement for calcium ionophores in this process, we transfected cells with a COOH-terminal deletion mutant (ACnA) of calcineurin which is constitutively active even in the absence of elevated calcium (Fig.  5 A; Hubbard and Klee, 1989; Clipstone and Crabtree, 1992; O'Keefe et al., 1992) . As with cells expressing fulllength CnA and CnB, cells expressing ACnA and CnB appear normal 16 h after transfection (Fig. 5 B, upper panel) .
In contrast to cells expressing the full-length CnA and CnB, those transfected with ACnA and CnB initiated apoptosis without exposure to calcium ionophores (Fig. 5 B, lower panel). Further, these cells reacted positively for fragmented D N A using the T U N E L method (Fig. 5 B, right panels). The time course for cell death after the start of serum deprivation of ACnA/CnB-transfected cells was remarkably rapid and approached 50% by 4 h (Fig. 5 C) . The absolute percentage of apoptotic cells was not obviously enhanced by the addition of ionomycin at four hours (Fig. 5 C) . These data indicate that calcineurin can directly stimulate apoptotic pathways without the cooperation of other calcium-activated proteins.
Correlation between Calcineurin Catalytic Activity and Apoptosis
To probe the relationship between C n A phosphatase activity and cell death, we scored cells transfected with increasing amounts of ACnA/CnB for both apoptosis and calcineurin enzymatic activity. Anti-calcineurin antibodies were used in immunoblots to assay calcineurin accumulation in the transfected cells (Parsons et al., 1994) . As seen in Fig. 6 A, A C n A (50 kD) migrates below endogenous calcineurin (60 kD) and its level of expression correlates with the amount of ACnA plasmid used in the transfection. To determine if the increased accumulation of ACnA is reflected in enhanced calcineurin activity, HA-tagged ACnA was immunoprecipitated with the anti-HA antibody and assayed for activity in vitro. We found a nearly Immunoprecipitates were assayed for phosphatase activity against the -~2P-labeled RII peptide, as described (Milan et al., 1994) . Apoptosis was scored on identical coverslips after 4 h of serum deprivation. Open circles and closed circles represent the percentage of apoptotic cells and phosphatase activity of the expressed calcineurin, respectively. (C) To compare the phosphatase activity of transfected ACnA with that of endogenous calcineurin, whole cell lysates were prepared from cells transfected with different amounts of ACnA/CnB and control vector alone (total 2 txg). Calcineurin-specific phosphatase activity was determined in the presence of 500 nM okadaic acid to suppress PP1 and PP2A . Lysates from cells transfected with vector alone displayed calcium-dependent and -independent phosphatase activity, both of which were suppressed by 500 nM CsA and 1 IxM cyclophilin B. Lysates made from ACnA/ CnB-transfected cells, assayed in the absence of calcium, displayed phosphatase activity proportional to the amount of ACnA/CnB transfected. The decrease in phosphatase activity at 1 linear relationship between the amount of calcineurin plasmids transfected and the phosphatase activity of the immunoprecipitated calcineurin (Fig. 6 B) . Moreover, these experiments revealed a strong correlation between calcineurin activity and apoptosis in transfected cells (Fig. 6 B) . We next asked how this transfected calcineurin activity compared to that of endogenous calcineurin. Cells transfected with a control vector were lysed in extraction buffer and assayed for calcineurin activity in the presence of okadaic acid (500 nM), which inhibits protein phosphatase 1 and 2A . In parallel, we performed phosphatase assays on lysates from cells transfected with increasing amounts of ACnA/CnB, and found a corresponding increase in phosphatase activity (Fig. 6 C) , as expected from the immunoprecipitation experiments. At the lowest amount of ACnA/CnB transfected, the lysates yielded a twofold higher calcineurin activity than that found in cells transfected with the control vector alone (Fig. 6 C) . At this level of calcineurin activity, 23% of cells undergo apoptosis after 4 h of serum deprivation, versus 3% for control vector-transfected cells. In transfections involving 0.75 txg ACnA/CnB, lysates show approximately eight times the endogenous level of calcineurin catalytic activity, and ~40% of total cells undergo apoptosis. Overall, these results indicate a strong relationship between cap cineurin-dependent phosphatase activity and cell death.
Discussion
Calcium signaling has been implicated in a wide variety of apoptotic stimuli and yet the critical effectors of calcium remain obscure. We provide evidence that the activation of calcineurin, a calcium/calmodulin-dependent phosphatase, rapidly provokes apoptosis and is therefore a likely mediator of calcium signaling leading to cell death. We show that calcineurin-induced cell death is abrogated by growth factor stimulation and by Bcl-2 expression. Further, calcineurin was shown to function at a posttranslational level to activate apoptosis. These data support the prospect that calcineurin is acting in a calcium-dependent manner to modify existing substrates important in the commitment to cell death.
Role of Calcineurin in Calcium-activated Cell Death
Despite advances in defining proteins which regulate apoptosis, including Bcl-2, Bax, ICE/Ced-3, and Ced-4, it is unclear how these factors are influenced by signal transduction pathways that promote cell death. Calcium signaling is associated with glucocorticoid-and activation-induced cell death in immature T cells, growth factor withdrawal in certain cell lines, and hyperactivation of N-methyl-D-aspartate receptors of neurons (Burr and Tomei, 1994; Martin et al., 1994; Reed, 1994) . In neurons of the central nervous system, calcium mobilization following glutamate stimulation of N-methyl-D-aspartate receptors is strongly implicated in cell death, although the identity of the calciumpxg ACnA/CnB (each 1 p~g of ACnA and CriB) is likely due to the induction of apoptosis observed even in the presence of 10% FCS (not shown).
sensitive mediators of apoptosis remains unclear (Choi, 1992) . The calcium-sensitivity of nitric oxide synthetase makes this enzyme an obvious candidate for effecting cell death in neurons (Choi, 1992) . However, calcineurin is present at very high concentrations (1-2 p,M) in the central nervous system (Krinks et al., 1984) , and therefore may be a material factor in calcium-activated cell death in neurons.
We provide several lines of evidence that calcineurin activity resulting from elevated intracellular calcium concentration, rather than additional calcium-activated events, is sufficient to induce cell death. For one, over-expression of the catalytic and regulatory subunits of calcineurin in fibroblasts renders these cells highly vulnerable to a rapid form of cell death. As with c-myc over-expression, these cells execute cell death processes only in the absence of growth factor stimulation. Second, cells expressing ACnA, which displays calcium-independent phosphatase activity, undergo apoptosis in the absence of calcium signaling. Further, the extent of apoptosis in a population of cells appears to correlate well with the phosphatase activity generated by the expressed ACnA. That calcineurin is a direct activator of cell death is supported by the observation that calcineurin promotes cell death in the absence of de novo protein synthesis. Similarly, neither c-myc nor p53 requires new protein synthesis to trigger apoptotic pathways (Evan et al., 1992; Caelles et al., 1994; Wagner et al., 1994 ).
It is possible, then, that both c-rnyc, as a complex with Max, and p53, function in cell death by repressing genes required for survival. Alternatively, these transcriptional activators may be involved in protein-protein interactions independent of transcriptional regulation to affect cell death decisions (Amati et al., 1993; Caelles et al., 1994; Wagner et al., 1994) . Calcineurin may participate in cell death pathways by indirectly altering transcriptional regulation through, for instance, c-myc or p53. Alternatively, calcineurin may function by affecting regulators of cell death such as Bcl-2 or Ced-3 (Yuan et al., 1993) .
Regulation of Calcineurin-induced Cell Death by Bcl-2 and Growth Factors
The ability of Bcl-2/Ced9 to prevent apoptosis due to a diverse array of stimuli, including ones involving calcium signaling, suggests that it regulates a fundamental step in the commitment to cell death (Sentman et al., 1991; Barr and Tomei, 1994; Hengartner and Horvitz, 1994; Reed, 1994) . We find that Bcl-2 efficiently suppresses apoptosis in cells transfected with wild type CnA and CnB, an indication that Bcl-2 blocks steps affected by calcineurin's phosphatase activity. Bcl-2 has been implicated in the regulation of both oxygen radical formation and calcium fluxes from intracellular stores, and conceivably either function could affect calcineurin-induced cell death (Hockenbery et al., 1993; Lam et al., 1994) .
Our results also demonstrate that growth factors in serum interfere with calcineurin-induced cell death. IGF-1 has been has been shown to block c-myc-induced apoptosis in fibroblasts (Evan et al., 1992; . Significantly, IGF-1 prevents cell death even in the absence of new protein synthesis, an indication that IGF-1 operates through pathways that directly impact apoptotic decisions . Cell death via c-myc is known to depend on wild-type p53, as c-myc over-expression in p53 n"u cell lines leads to proliferation rather than cell death (Hermeking and Eick, 1994) . The ability of c-rnyc expressing p53 nutt cells to avoid cell death is thought to underlie tumor progression in many human cancers (Burr and Tomei, 1994) . We are currently testing the possibility that calcineurin, c-myc, and p53 interact in a common regulatory scheme to influence decisions on cell death.
Calcineurin Function in Apoptosis is Fundamentally Different from That in T Cell Activation
A role for calcineurin in cell death has been deduced from earlier studies of T cell activation. T cell hybridomas, and in some cases, immature T cells, undergo cell death in a calcium-dependent manner thought to require calcineurin (Smith et al., 1989; . But several features of cell death in T cell hybridomas suggest that it occurs via pathways distinct from those employed in the calcineurin-dependent apoptosis described here in fibroblasts. For one, T cell hybridomas stimulated by anti-CD3 antibodies appear to undergo the early phases of T cell activation including calcium mobilization, Nuclear Factor in Activated T Cells (NFAT) activation, and cytokine transcription within 30 min, and yet cell death is not evident for another six to eight hours (Shi et al., 1989; Smith et al., 1989; Ucker et al., 1989; Fruman et al., 1994) . It is now known that much of this lag is due to the requirement of new protein synthesis for T cell hybridoma death (Ucker et al., 1989; Crispe, 1994) . In contrast, the failure of cycloheximide to impede ceil death in fibroblasts overexpressing calcineurin suggests that calcineurin acts to modify substrates essential for apoptosis which already exist in the cell. This finding supports previous work which argued that important components of the cell death process are constitutively expressed in the cell (Raft et al., 1993) . Moreover, the immunosuppressants CsA and FK506, which block apoptosis in T cell hybridomas, fail to block the more direct cell death in BHK fibroblasts described here (Shibasaki, F., and F. McKeon, manuscript in preparation). This apparent dichotomy underscores the possibility of two distinct, calcineurin-dependent pathways leading to cell death. In T cell hybridomas, CsA blocks the early phase of T cell activation which is necessary to promote the subsequent, Fas-dependent process of cell death (Singer and Abbas, 1994) . On the other hand, the more direct, calcineurin-dependent pathways described here may involve substrates favored by calcineurin-CsA-cyclophilin complexes (Liu et al., 1991) .
In summary, we have shown that calcineurin can mediate calcium-activated cell death in mammalian cells in a manner regulated by the Bcl-2 oncoprotein and growth factors. The calcineurin expression system described here provides an important model for the analysis of signal transduction pathways that directly influence the decision towards cell death or growth. Finally, these results suggest that calcineurin may act in the calcium-activated cell death of neurons and cells of the immune system. the Human Frontier Science Program (LT-138/93). This work was supported by a grant from the American Cancer Society (IM-665) to F. McKeon.
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